Thermo Fisher Scientific Announces Extended 510k Clearance of Freelite Assays for Evaluation of MGUS, a Precursor to Multiple Myeloma
TalkMed Unit Signs MOU With Thermo Fisher
Universal Health Services & Lockheed Martin Were Among Top 11 Large Cap Stocks That Shined The Brightest Last Week (July 21-July 27): Are The Others In Your Portfolio?
Why Is Thermo Fisher Scientific Inc. (TMO) the Best Scientific Instrument Stock to Buy Now?
Here's How Much $100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today
Microbial Detection Systems Market Insights and Forecast, 2024-2032 - BD, Danaher, Thermo Fisher Scientific, BioMerieux, QIAGEN, and Shimadzu Account for ~44% Total Market Share
Single Nucleotide Polymorphism (SNP) Genotyping: Technologies and Global Markets to 2029 Featuring Profiles of Agilent Technologies, Roche, Illumina, Qiagen, and Thermo Fisher Scientific
Morgan Stanley Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Raises Target Price to $655
Results: Thermo Fisher Scientific Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Thermo Fisher Scientific Second Quarter 2024 Earnings: EPS Beats Expectations
Evercore Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Maintains Target Price $605
Thermo Fisher Price Target Raised to $658.00/Share From $648.00 by TD Cowen
Thermo Fisher Is Maintained at Buy by TD Cowen
Apple To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Thursday
Express News | Thermo Fisher Shares Are Trading Higher After Multiple Analysts Raised Their Price Targets on the Stock Following Wednesday's Earnings Report
Raymond James Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Raises Target Price to $660
Navigating 5 Analyst Ratings For Thermo Fisher Scientific
A Quick Look at Today's Ratings for Thermo Fisher Scientific(TMO.US), With a Forecast Between $600 to $664
Thermo Fisher Scientific Showcases Diagnostics Innovation Across Therapeutic Areas at ADLM 2024
Jefferies Adjusts Price Target on Thermo Fisher Scientific to $655 From $650, Maintains Buy Rating